Skip to content
Home/Companies/MedTech/Decon

Decon

MedTech·Sweden·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns Decon?

Decon is currently owned by Impilo through Impilo Investment Pool 2 (2021 vintage), since 2023.

Hand-verified · updated 2026-08-17

Impilo
Investor
Impilo
Impilo Investment Pool 2 · 2021 · Buyout

Key facts

HQSweden
SectorMedTech
StatusActive

More from Impilo Investment Pool 2

Other portfolio companies in the same fund.

Avia Pharma
Active
PharmaSweden· 2024
Qufora
Active
MedTechDenmark· 2024
Tandlaegen.dk
Active
HealthcareDenmark· 2024
Pelago Bioscience
Active
PharmaSweden· 2023
Stille
Active
MedTechSweden· 2023
VaccinDirekt
Active
HealthcareSweden· 2023

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Biocomposites
Biocomposites
Active
TA AssociatesUS
CMR Surgical
CMR Surgical
Active
LightrockUK
Neuromod Devices
Neuromod Devices
Active
Enterprise IrelandIreland
Optos
Exited 2015
Amadeus Capital PartnersUK
to
Ardos
Active
Delphinus Venture CapitalDenmark· 2026
Axomove
Axomove
Active
Go CapitalFrance· 2026
Track Decon

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Decon?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Decon.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue